Intensive education
BehavioralParticipants will attend a 3 day family-centered, multidisciplinary, intensive education session at our regional diabetes camp, Camp Sweeney. A second 'booster' session will be conducted 6 months later.
NCT Number: NCT02432586
18 preschool aged children and their families will attend structured, multidisciplinary, family-centered intensive education sessions over a 3-day weekend in a residential camp setting to address the unique challenges of managing type 1 diabetes mellitus in young children. A second 'booster' session, will be conducted 6 months later.
Looking for future studies?
Notify Me34 month–68 month
All sexes
Interventional
Not applicable
We propose to deliver a structured multidisciplinary family-centered intervention over a 3-day weekend, with a second similar "booster" session 6 months later. The intervention will be based at our regional diabetes camp, Camp Sweeney. The proposed camp encounters aim to provide:
We will conduct this pilot study, which will enroll 18 preschool children age 3-5.5 years, with the goal of obtaining preliminary results for 15 subjects.
The primary outcome, to be determined approximately one month before and after each of the two camp sessions, is improvement in Hemoglobin A1c (HbA1c). This outcome will be compared with that of historical controls.
Exploratory Hypotheses:
Compared with pretreatment baseline and historical controls, subjects attending two 3-day sessions at a family diabetes camp will improve:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will attend a 3 day family-centered, multidisciplinary, intensive education session at our regional diabetes camp, Camp Sweeney. A second 'booster' session will be conducted 6 months later.
Time frame: One month pre-camp, one month post-camp
As compared to historical controls
Time frame: One month pre-camp, one month post-camp
As compared to historical controls
Time frame: One month pre-camp, one month post-camp
As measured by continuous glucose monitoring, and quantitated as area under the curve for blood glucoses <70 mg/dL.
Time frame: One month pre-camp, one month post-camp
As measured by continuous glucose monitoring, and quantitated as area under the curve for blood glucoses <70 mg/dL.
Time frame: Duration of participation in study, expected to be 10 months
Composite measure. As compared to historical controls.
Time frame: One month pre-camp, one month post-camp
Parent report
Time frame: One month pre-camp, one month post-camp
Parent report
Time frame: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
Time frame: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
Time frame: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
Time frame: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
Time frame: One month pre-camp, one month post-camp
Parents of young children version
Time frame: One month pre-camp, one month post-camp
Parents of young children version
Time frame: One month pre-camp, one month post-camp
Behavior section
Time frame: One month pre-camp, one month post-camp
Behavior section
University of Texas Southwestern Medical Center
Other
Acronym: TotCamp
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07561086
Autoimmune Diseases, Diabetes Mellitus
Marsá Maţrūḩ, Mersa Matrouh, Egypt
View Trial DetailsNCT07177404
Autoimmune Diseases, Diabete Mellitus
Derby, United Kingdom
View Trial DetailsNCT03475108
Autoimmune Diseases, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00639964
Autoimmune Diseases, Diabetes Mellitus
Lille, France
View Trial Details